Ophthalmic Imaging Systems (“OIS”) designs, develops, manufactures and markets digital imaging systems and informatics solutions for the eye care market. The company has 25 years experience in the ophthalmic imaging business and is the leading provider of ophthalmic digital imaging systems.

The company today announced that it will launch two new products and improvements to the OIS EMR and OIS PM solutions at the American Academy of Ophthalmology ’s 113th annual meeting to be held October 24-27 in San Francisco. The two new products are specifically targeted to address the shift in healthcare demand due to aging populations and the rapid rise in diabetic-related eye disease.

The new product launches are:

OIS EyeScan – The OIS EyeScan is the first totally new imaging device the company has launched in a few years. It is a revolutionary new portable imaging device has wide-ranging functionality that is capable of imaging both the anterior and

...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Friday October 9, 2009

DrStockPick.com Stock Report!

**************************************************************

Danvers Bancorp, Inc. (NASDAQ: DNBK) announced that at a special meeting of its stockholders held on October 9, 2009, Danvers stockholders voted to approve the Agreement and Plan of Merger by and between Danvers and Beverly National Corporation (NYSE Amex: BNV), dated as of June 16, 2009, pursuant to which Beverly National Corporation will merge with and into Danvers.

Valley National Bank, the wholly-owned subsidiary of Valley National Bancorp (NYSE: VLY) announced today that DBRS, a globally recognized provider

...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Thursday October 1st, 2009

DrStockPick.com Stock Report!

**************************************************************

FIMA, Inc. (PINKSHEETS: FIMA), an emerging land development company, announced today that in spite of the continued persistent negative economic climate, the Company’s assets have remained steady. FIMA management, in order to control expenditures in light of its expectations for the direction of the economy, earlier this year decided upon a strategy that involved the dissolution of certain subsidiaries that were deemed unlikely to produce significant profits within an acceptable time frame. In addition, management revised its strategy in

...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Tuesday September 22, 2009

DrStockPick.com Stock Report!

**************************************************************

The Carbon Disclosure Project, which holds the largest database of corporate climate change information in the world, has recognized Air Products’ (NYSE: APD) approach to climate change disclosure and named the company to its Leadership Index for 2009.

Flushing Financial Corporation (Nasdaq:FFIC), the parent holding company for Flushing Savings Bank, announced today that it has completed its public offering of 8,317,400 shares of common stock at a price of $11.50 per share. The net proceeds of the

...

Imaging3, Inc.

(Public, OTC:IMGG)

A new and radical medical device from Imaging3 Inc. (OTC:IMGG) is ready to set the standard, and revolutionize the way we look at X-ray, MRI and CT scans. Imaging 3 is currently awaiting FDA approval on their DViS (Dominion Volumetric Imaging Scanner). Currently, medical imaging is met with challenges of long waits, lack of space, lack of mobility, and limited uses. However, for the first time ever, health-care workers will be able to instantly view 3D, high-resolution images of virtually any part of the human body. Thus, Imaging 3 looks to change all that. Saving time, saving lives and reducing costs. This technology will “set the standard for the next 10 years.” The following article was composed by StocksHaven Investments alongside Professor Philip Runfeldt, a Behavioral Analyst who has worked with Fortune 500 companies and major Universities throughout

...

Cell Biosciences, Inc., a private life sciences company focused on nanoproteomics, and Alpha Innotech Corp., a leading developer, manufacturer and marketer of digital imaging and analysis systems, recently announced that Cell Biosciences will acquire Alpha Innotech for $1.50 per share or approximately $17.9 million in cash. In 2008, Alpha Innotech achieved revenues of $17.6 million and was profitable on both an operating and a net income basis.

The completion of the transaction is subject to customary terms and conditions, including approval by the Alpha Innotech stockholders. The directors, executive officers and certain stockholders of Alpha Innotech, who collectively hold approximately 33 percent of the company’s outstanding common stock, have entered into agreements with Cell Biosciences pursuant to which they have agreed to vote their shares of Alpha Innotech common stock in favor of the transaction. The transaction is expected to be completed within the next 60 days.

Commenting on the acquisition,

...

Stryker Corporation (SYK), one of the world’s largest medical device companies operating in the global orthopedic market, reported its financial results for the second quarter of fiscal 2009. Net sales in the quarter were $1,634.3 million, a decline of 4.6% year over year. The company was hurt by a slowdown in MedSurg businesses and foreign currency (FX) headwinds. Excluding FX, net sales were roughly flat, compared to last year.

In terms of business segments: Orthopaedic Implants sales were roughly flat year over year at $1,014.2 million. The company witnessed strong U.S. sales buoyed by higher shipments of reconstructive, trauma, spinal and craniomaxillofacial implant systems. However, international sales were lower due to currency headwinds. MedSurg Equipment sales declined 11% year over year to $620.1 million. This segment was hurt by the global economic slowdown with patients delaying their surgical operations. Lower shipments of surgical equipment and surgical navigation systems, endoscopic, communications

...

QuoteMedia, Inc. (OTCBB: QMCI) has positioned themselves as a leading provider in the financial data market industry. The company has created an advanced and provocative model that aggregates, manages, and streams information to multiple entities from the major exchanges in the U.S., Canada, and Europe. Ultimately, this enables their clients and customers to license comprehensive financial market information and software applications for a reduced cost compared to other providers.

Leading the way at QuoteMedia, Inc. is Keith Guelpa, president and CEO. Mr. Guelpa’s career comprises more than thirty years of high-ranking positions in the telecommunications, digital imaging, and Internet communications industries. He has served as the COO/president of a public company offering brokering services, financial planning, and investment banking consulting. Mr. Guelpa is also the co-founder and director of the company.

Having more than forty years of distinguished business and consulting experience is Robert J. Thompson, C.A., C.M.C., the

...

Chairman of the Board Ronald Erickson has over 25 years of experience in the high technology, telecommunications and micro-computer industries. In addition to his service to Visualant, he is the current Chair, and former CEO of eCharge, an electronic payment systems developer, where he played a key role in raising approximately US$100 million in equity capital from major international investors. Mr. Erickson was also co-founder, Chairman, President and CEO of GlobalTel Resources, Inc., a provider of telecommunications services, messaging and intranet solutions, and has held executive positions at Egghead Software Inc, NBI Inc, and MicroRim, Inc.

President and CEO Bradley E. Sparks brings more than three decades of expertise in the high-tech and related industries. He has experience guiding high-tech startup companies through IPO’s and has served in senior financial positions for major public companies. Previous to Visualant, Mr. Sparks was the CFO of WatchGuard Technologies, Inc. which was recently

...

Zoran Corporation's (ZRAN) revenues in the last few quarters were disappointing, with several sectors being influenced by the poor economic environment.The company's guidance for a significant slowdown in business activity was well below the analyst consensus. Cash flow is positive, excluding acquisitions, and total cash should provide a buffer to further declines in stock price.Our price target remains at $15.00 and our recommendation is a BUY. Zoran Corp. is a leading provider of digital solutions for applications in the growing digital entertainment and digital imaging markets.Read the full analyst report on ZRAN "ZRAN" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research